Related Experiment Video
Updated: May 1, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Synthesis and biological activity of some bile acid-based camptothecin analogues
Xingnuo Li1, Tengfei Zhao2, Dongping Cheng3
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. lixingnuo@zjut.edu.cn.
Abstract:
In an effort to decrease the toxicity of camptothecin (CPT) and improve selectivity for hepatoma and colon cancer cells, bile acid groups were introduced into the CPT 20 or 10 positions, resulting in the preparation of sixteen novel CPT-bile acid analogues. The compounds in which a bile acid group was introduced at the 20-hydroxyl group of CPT showed better cytotoxic selectivity for human hepatoma and colon cancer cells than for human breast cancer cells. Fluorescence microscopy analysis demonstrated that one compound (E2) entered human hepatoma cells more effectively than it did human breast cancer cells. Compound G4 exhibited the best anti-tumour activity in vivo. These results suggested that introduction of a bile acid group at the 20-position of CPT could decrease toxicity in vivo and improve selectivity for hepatoma cells.
Insights
Researchers developed novel camptothecin (CPT) analogues by attaching bile acid groups. These compounds show improved selectivity for hepatoma and colon cancer cells, with one analogue demonstrating significant anti-tumour activity in vivo.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Camptothecin (CPT) is a potent anti-cancer agent but suffers from high toxicity and poor selectivity.
- Developing CPT analogues with improved therapeutic profiles is crucial for effective cancer treatment.
Purpose of the Study:
- To synthesize novel camptothecin-bile acid analogues to reduce CPT toxicity and enhance selectivity for hepatoma and colon cancer cells.
- To evaluate the in vitro and in vivo anti-cancer efficacy of these novel analogues.
Main Methods:
- Synthesis of sixteen novel CPT-bile acid analogues by introducing bile acid groups at the CPT 20 or 10 positions.
- In vitro cytotoxicity assays against human hepatoma, colon, and breast cancer cell lines.
- Fluorescence microscopy to assess cellular uptake of selected analogues.
- In vivo anti-tumour activity evaluation of the most promising analogue.
Main Results:
- CPT analogues with bile acid groups at the 20-hydroxyl position exhibited enhanced cytotoxic selectivity for hepatoma and colon cancer cells over breast cancer cells.
- One analogue (E2) demonstrated superior cellular uptake in hepatoma cells compared to breast cancer cells.
- Compound G4 displayed the most potent anti-tumour activity in vivo.
Conclusions:
- Introduction of bile acid groups, particularly at the 20-position of CPT, can significantly decrease toxicity and improve selectivity towards hepatoma cells.
- These novel CPT-bile acid analogues represent promising candidates for further development as targeted anti-cancer therapeutics.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
